Skip to content
EntityQ7160547· pop 16· linked from 282 articles

pegaspargase

Sign in to save

Also known as L-asparagine amidohydrolase, putative L-asparaginase precursor

Pegaspargase, sold under the brand name Oncaspar, is a medication used in the treatment of acute lymphoblastic leukemia (ALL). Often it is used together with anthracycline, vincristine, and corticosteroids (for example prednisone and dexamethasone). Pegaspargase can be administered either via an intravenous infusion or a intramuscular injection.

Key facts

Drug.Verifiedfields
changed
Drug.verifiedrevid
458268975
Drug.image
Pegaspargasa.png
Drug.tradename
Oncaspar
Drug.MedlinePlus
a695031
Drug.DailyMedID
Pegaspargase
Drug.pregnancy_AU
D
Drug.routes_of_administration
Intramuscular, intravenous
Drug.ATC_prefix
L01
Drug.ATC_suffix
XX24
Drug.legal_AU
S4
Drug.legal_CA
Rx-only
Drug.legal_US
Rx-only
Drug.legal_EU
Rx-only
Drug.CAS_number
130167-69-0
Drug.DrugBank
DB00059
Drug.ChemSpiderID
none
Drug.UNII
7D96IR0PPM

via Wikipedia infobox

Research

547 papers

via PubMed

Wikidata facts

Show 1 more fact
World Health Organisation international non-proprietary name
pegaspargase
Sources (2)

via Wikidata · CC0

~1 min read

Article

1 sections
Contents
  • References

Pegaspargase, sold under the brand name Oncaspar, is a medication used in the treatment of acute lymphoblastic leukemia (ALL). Often it is used together with anthracycline, vincristine, and corticosteroids (for example prednisone and dexamethasone). Pegaspargase can be administered either via an intravenous infusion or a intramuscular injection.

Known side effects include allergic reactions, coagulopathy, high blood sugar, affecting liver function, pancreas inflammation, and blood clots in the brain. There is no data regarding the usage of pegaspargase during pregnancy. Therefore, caution should be observed and pegaspargase should only be used during pregnancy when the benefits outweigh the possible risks.

Connections

Categories